Unknown

Dataset Information

0

Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.

ABSTRACT: To clarify the cellular mechanisms for the establishment of prion infection, we analyzed the intracellular dynamics of inoculated and newly generated abnormal isoform of prion protein (PrP(Sc)) in Neuro2a cells. Within 24h after inoculation, the newly generated PrP(Sc) was evident at the plasma membrane, in early endosomes, and in late endosomes, but this PrP(Sc) was barely evident in lysosomes; in contrast, the majority of the inoculated PrP(Sc) was evident in late endosomes and lysosomes. However, during the subsequent 48 h, the newly generated PrP(Sc) increased remarkably in early endosomes and recycling endosomes. Overexpression of wild-type and mutant Rab proteins showed that membrane trafficking along not only the endocytic-recycling pathway but also the endo-lysosomal pathway is involved in de novo PrP(Sc) generation. These results suggest that the trafficking of exogenously introduced PrP(Sc) from the endo-lysosomal pathway to the endocytic-recycling pathway is important for the establishment of prion infection.

SUBMITTER: Yamasaki T 

PROVIDER: S-EPMC4167762 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.

Yamasaki Takeshi T   Baron Gerald S GS   Suzuki Akio A   Hasebe Rie R   Horiuchi Motohiro M  

Virology 20140115

To clarify the cellular mechanisms for the establishment of prion infection, we analyzed the intracellular dynamics of inoculated and newly generated abnormal isoform of prion protein (PrP(Sc)) in Neuro2a cells. Within 24h after inoculation, the newly generated PrP(Sc) was evident at the plasma membrane, in early endosomes, and in late endosomes, but this PrP(Sc) was barely evident in lysosomes; in contrast, the majority of the inoculated PrP(Sc) was evident in late endosomes and lysosomes. Howe  ...[more]

Similar Datasets

Unknown Anti-prion drug mPPIg5 inhibits PrP(C) conversion to PrP(Sc).
| S-EPMC3557256 | biostudies-other
Unknown Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.
| S-EPMC3347255 | biostudies-literature
Unknown Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP<sup>Sc</sup> and Targeting PrP<sup>Sc</sup> for Lysosomal Degradation.
| S-EPMC6326903 | biostudies-literature
Unknown Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids.
| S-EPMC4294479 | biostudies-literature
Unknown The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
| S-EPMC2827544 | biostudies-literature
Unknown PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice.
| S-EPMC4134347 | biostudies-literature
Unknown Glial activation in prion diseases is selectively triggered by neuronal PrP<sup>Sc</sup>.
| S-EPMC9425016 | biostudies-literature
Unknown Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP<sup>Sc</sup>.
| S-EPMC6102138 | biostudies-literature
Unknown Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
| S-EPMC4964868 | biostudies-literature
Unknown The N-terminal sequence of prion protein consists an epitope specific to the abnormal isoform of prion protein (PrP(Sc)).
| S-EPMC3585212 | biostudies-literature